Evaluation of the effect of Erectofix device in solving prostate Inflammation symptoms and complications

Evaluation of the effect of Erectofix device in solving prostatitis symptoms and complications

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230408057854N2

Enrollment

Registered

2023-05-13

Start date

2023-06-22

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostatitiis. Inflammatory diseases of prostate

Interventions

Intervention 1: Using the Higgs laser. Intervention 2: Control group: standard treatment.

Eligibility

Sex/Gender

Male

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 20-65 years Have symptoms of chronic prostatitis

Exclusion criteria

Exclusion criteria: History of urological surgery leading to regional nerve cutting, regional vascular damage A history of trauma to the genital area that caused neurological or vascular defects in the area History of medical diseases (diabetes, high blood pressure, blood lipid disorders, thyroid disorders and severe depression)

Design outcomes

Primary

Measure	Time frame
Pain and discomfort in the perineum. Timepoint: A course of 5 consecutive sessions twice a week. Method of measurement: Questionnaire related to chronic prostatitis (NIH-CPSI score).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Rahnama

Shahid Beheshti University of Medical Sciences

rahnama2010@gmail.com+98 21 2271 8002

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026